Scott M. Hammer

23.4k citations

129 papers · 16.0k indexed · 10 hit papers · h-index 52

Impact in

Virology top 0.01%
- HIV Research and Treatment
Infectious Diseases top 0.02%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions

Papers in

Virology 86
- HIV Research and Treatment 86
Infectious Diseases 87
- HIV/AIDS drug development and treatment 74
- HIV/AIDS Research and Interventions 68

Co-authors: Margaret A. Fischl Douglas D. Richman Donna M. Jacobsen Martin Hirsch Melanie Thompson Paul A. Volberding David Katzenstein Robert T. Schooley
Journals: The Journal of Infectious Diseases (11 papers)JAMA (11 papers)AIDS Research and Human Retroviruses (9 papers)Clinical Infectious Diseases (8 papers)AIDS (7 papers)
Partner nations: United States Spain France

In The Last Decade

Scott M. Hammer

126 papers receiving 15.3k citations

Hit Papers

10 papers align trajectories log scale

Antiretroviral Treatment of Adult HIV Infection 2012 · 1.4k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2012 JAMA
2010 JAMA
2008 JAMA
2006 JAMA
2004 JAMA
2002 JAMA
2000 JAMA
1998 JAMA
1997 New England Journal of Medicine
1996 New England Journal of Medicine

Peers

Countries citing papers authored by Scott M. Hammer

Since Specialization

Citations

This map shows the geographic impact of Scott M. Hammer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott M. Hammer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott M. Hammer more than expected).

Fields of papers citing papers by Scott M. Hammer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott M. Hammer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott M. Hammer. The network helps show where Scott M. Hammer may publish in the future.

Co-authors

The 25 scholars most cited alongside Scott M. Hammer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Scott M. Hammer Line = papers co-authored together Scott M. Hammer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The association of α4β7 expression with HIV acquisition and disease progression in people who inject drugs and men who have sex with men: Case control studies EBioMedicine ·Alyssa R. Martin, Eshan U. Patel, Charles Kirby, Jacquie Astemborski, Gregory D. Kirk, Shruti H. Mehta, Kyle Marshall, Holly Janes, M Siroki, Lawrence Corey, Scott M. Hammer, Magdalena E. Sobieszczyk, James Arthos, Claudia Cicala, Andrew D. Redd, Thomas C. Quinn	2020	4
2	Implementing Good Participatory Practice (GPP) in HVTN505 - The HIV Vaccine Trials Network (HVTN) Experience AIDS Research and Human Retroviruses ·Gail Broder, James Maynard, Shelly Karuna, Chuka Anude, Magda Sobieszczyk, Scott M. Hammer, (unknown)	2014	1
3	Patterns of Geographic Mobility Predict Barriers to Engagement in HIV Care and Antiretroviral Treatment Adherence AIDS Patient Care and STDs ·Barbara S. Taylor, 郑王娜, Alessandro Procaccini, yvon Autret, Stahl Kurt, Yeycy Donastorg, Scott M. Hammer, Karen Brudney, Jennifer S. Hirsch	2014	64
4	In Pursuit of an HIV Vaccine: Designing Efficacy Trials in the Context of Partially Effective Nonvaccine Prevention Modalities AIDS Research and Human Retroviruses ·Holly Janes, Peter B. Gilbert, Susan Buchbinder, James G. Kublin, Magdalena E. Sobieszczyk, Scott M. Hammer	2013	15
5	Translational Research Insights From Completed HIV Vaccine Efficacy Trials JAIDS Journal of Acquired Immune Deficiency Syndromes ·Hong‐Van Tieu, Morgane Rolland, Scott M. Hammer, Magdalena E. Sobieszczyk	2013	3
6	Advances in antiretroviral therapy. PubMed ·Barbara S. Taylor, Susan Olender, Timothy Wilkin, Scott M. Hammer	2012	18
7	Transmitted Drug Resistance Among Antiretroviral-Naive Patients with Established HIV Type 1 Infection in Santo Domingo, Dominican Republic and Review of the Latin American and Caribbean Literature AIDS Research and Human Retroviruses ·Julie E. Myers, Barbara S. Taylor, Dulce María Irene, 郑王娜, Catherine Vaughan, H. Ulrici, P VAIDYAN, Henny Patricia Carvajal Villamizar, Maria Paula Torrenegra Murcia, B. Stryukov Michael, Yolanda Lie, Eoin Coakley, Scott M. Hammer, Karen Brudney	2011	18
8	A Randomized, Placebo-Controlled Trial of Abacavir Intensification in HIV-1–Infected Adults With Virologic Suppression on a Protease Inhibitor–Containing Regimen HIV Clinical Trials ·Scott M. Hammer, Heather J. Ribaudo, Roland Bassett, John W. Mellors, Lisa M. Demeter, Robert W. Coombs, Judith S. Currier, Gene D. Morse, John G. Gerber, Ana I. Martínez, William Spreen, Margaret A. Fischl, Kathleen Squires, (unknown)	2010	16
9	Vitamin D deficiency in HIV-infected postmenopausal Hispanic and African-American women Osteoporosis International ·Emily M. Stein, Michael T. Yin, Donald J. McMahon, Aimee Shu, Orozco Yanza, David C. Ferris, Subkhana Adzim Baqi, Jay F. Dobkin, Scott M. Hammer, Elizabeth Shane	2010	41
10	Immunologic Markers as Predictors of Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome in HIV and Tuberculosis Coinfected Persons in Thailand AIDS Research and Human Retroviruses ·Hong‐Van Tieu, Jintanat Ananworanich, Anchalee Avihingsanon, Rossih Amira, Sunee Sirivichayakul, Umaporn Siangphoe, Yi Li, Élie S. Banyongen, Scott M. Hammer, Weerawat Manosuthi	2009	27
11	Antiretroviral Treatment of Adult HIV Infection JAMA ·Scott M. Hammer, Joseph J. Eron, Peter Reiss, Robert T. Schooley, Melanie Thompson, Sharon Walmsley, Pedro Cahn, Margaret A. Fischl, José M. Gatell, Martin Hirsch, Donna M. Jacobsen, Joan Montaner, Douglas D. Richman, Patrick Yéni, Paul A. Volberding Hit paper breakdown →	2008	832
12	Management of Newly Diagnosed HIV Infection New England Journal of Medicine ·Scott M. Hammer	2005	50
13	Comparison of Two Indinavir/Ritonavir Regimens in the Treatment of HIV-Infected Individuals JAIDS Journal of Acquired Immune Deficiency Syndromes ·Edward P. Acosta, Hulin Wu, Scott M. Hammer, Yu Song, Daniel R. Kuritzkes, Ann Walawander, Joseph J. Eron, Carl J. Fichtenbaum, Carla Pettinelli, Hu Qianqian, Elaine Ferguson, Alfred J. Saah, John G. Gerber	2004	59
14	A Randomized Trial of 2 Different 4‐Drug Antiretroviral Regimens versus a 3‐Drug Regimen, in Advanced Human Immunodeficiency Virus Disease The Journal of Infectious Diseases ·Margaret A. Fischl, Heather J. Ribaudo, Ann C. Collier, Alejo Erice, Marina Giuliano, Marjorie Dehlinger, Joseph J. Eron, Michael S. Saag, Scott M. Hammer, Stefano Vella, Gene D. Morse, Judith Feinberg	2003	69
15	Associations of CCR5, CCR2, and Stromal Cell–Derived Factor 1 Genotypes with Human Immunodeficiency Virus Disease Progression in Patients Receiving Nucleoside Therapy The Journal of Infectious Diseases ·Janet L. Lathey, Camlin Tierney, Julia Roensch, Richard T. D’Aquila, Sinsaku ONODERA, Heather C. Alexander, 仁加藤, Angela M. Hughes, Charlene F. Barroga, Stephen A. Spector, K Spiałek, Scott M. Hammer, David Katzenstein	2001	23
16	The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements AIDS ·Donald Brambilla, Patricia Reichelderfer, James W. Bremer, David E. Shapiro, Ronald C. Hershow, David Katzenstein, Scott M. Hammer, J. Brooks Jackson, Ann C. Collier, Rhoda Sperling, Mary Glenn Fowler, Robert W. Coombs	1999	59
17	Use of Changes in Plasma Levels of Human Immunodeficiency Virus Type 1 RNA to Assess the Clinical Benefit of Antiretroviral Therapy The Journal of Infectious Diseases ·Ian C. Marschner, Ann C. Collier, Robert W. Coombs, Richard T. D’Aquila, Victor DeGruttola, Margaret A. Fischl, Scott M. Hammer, Michael D. Hughes, Victoria A. Johnson, David Katzenstein, Douglas D. Richman, Laura Smeaton, Stephen A. Spector, Michael S. Saag	1998	182
18	MAJOR INFECTIOUS COMPLICATIONS AFTER ORTHOTOPIC LIVER TRANSPLANTATION AND COMPARISON OF OUTCOMES IN PATIENTS RECEIVING CYCLOSPORINE OR FK506 AS PRIMARY IMMUNOSUPPRESSION Transplantation ·WANG Zhao-yang, M.C. Samayoa, Aeon Alvarado Amaro, Roger L. Jenkins, Adolf W. Karchmer, Scott M. Hammer	1995	119
19	HIV-1 Tat modulates invasion by a bacterial enteric pathogen into a human intestinal cell line AIDS ·FRANK M. TABELLION, Christine Wanke, Bin Du, Scott M. Hammer, Ernest F. Terwilliger	1995	3
20	Ganciclovir Hepatotoxicity Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Brian F. Shea, Stephen L. Hoffman, Pau.A. Kyrle, Scott M. Hammer	1987	12

About Scott M. Hammer

Scott M. Hammer is a scholar working on Virology, Infectious Diseases, Transplantation, Epidemiology and Emergency Medicine, having authored 129 papers that have together received 16.0k indexed citations. Recurring topics across this work include HIV Research and Treatment (86 papers), HIV/AIDS drug development and treatment (74 papers), HIV/AIDS Research and Interventions (68 papers), Cytomegalovirus and herpesvirus research (14 papers), Herpesvirus Infections and Treatments (13 papers), Pneumocystis jirovecii pneumonia detection and treatment (11 papers), HIV-related health complications and treatments (9 papers) and Immune Cell Function and Interaction (7 papers). The work is most often cited by research in Virology (10.2k citations), Infectious Diseases (12.3k citations), Emergency Medicine (2.3k citations), Hepatology (886 citations) and Epidemiology (3.9k citations). Scott M. Hammer has collaborated with scholars based in United States, Spain and France. Frequent co-authors include Margaret A. Fischl, Douglas D. Richman, Donna M. Jacobsen, Martin Hirsch, Melanie Thompson, Paul A. Volberding, David Katzenstein, Robert T. Schooley, Patrick Yéni and Joseph J. Eron. Their work appears in journals such as The Journal of Infectious Diseases, JAMA, AIDS Research and Human Retroviruses, Clinical Infectious Diseases and AIDS.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact